HPV Test Aptima for Her
OVERVIEW
APTIMAFORHER.COM TRAFFIC
Date Range
Date Range
Date Range
APTIMAFORHER.COM HISTORY
SPAN
LINKS TO WEBSITE
WHAT DOES APTIMAFORHER.COM LOOK LIKE?
CONTACTS
QUEST DIAGNOSTICS INCORPORATED
1200 Wall Street West
Lyndhurst, NJ, 07071
UNITED STATES
QUEST DIAGNOSTICS INCORPORATED
QUEST DIAGNOSTICS INCORPORATED
1200 Wall Street West
Lyndhurst, NJ, 07071
UNITED STATES
APTIMAFORHER.COM SERVER
NAME SERVERS
BROWSER IMAGE
SERVER SOFTWARE
We identified that aptimaforher.com is employing the Apache/2.2.27 (Amazon) os.HTML TITLE
HPV Test Aptima for HerDESCRIPTION
Aptimas HPV Test is a significant innovation in cervical cancer screening, offering excellent accuracy with fewer false positives.PARSED CONTENT
The website states the following, "Your dedication to saving womens lives." I analyzed that the web page also stated " Is what drives us to offer." They also stated " One of the most significant innovations in. Cervical cancer screening in over a decade. Genotype for Types 16, 1845. Know the facts about the Aptima HPV Test. FDA-approved for use with ThinPrep. Aligns with cervical cancer screening guidelines. Requires only 1 mL of specimen. Same price and coverage as DNA-based HPV tests. No increased costs to you or your patients."ANALYZE OTHER WEB PAGES
Aptima Ventures was established by Aptima Inc. To identify and commercialize high-potential, early-stage technologies originating from Aptima and from leading universities and federally-funded research programs. We partner with entrepreneurs, companies, and venture investors, both global and domestic, to launch sophisticated product solutions oriented by intellectual property and strategic value. We are bringing to market l.
Ne ressemble à aucune autre,. Nous vous proposons des formations. Sur mesure et des suivis personnalisés. La Capelle - 81220 DAMIATTE - FRANCE. Vous avez suivi une formation avec APTIMENS? Votre témoignage nous intéresse, vous pouvez nous le communiquer par email. Est un cabinet de formation spécialisé dans le domaine de la Communication, du Management et du Développement Personnel.
Aptimmune Completes Series B Funding, Moves to St. Aptimmune Launches First Inactivated Mucosal IAV-S Vaccine. ISU and Aptimmune Improve PRRSV Isolation. Aptimmune Selected by Yield Lab for Ag Tech Accelerator Program. Novel Technology to Fight Swine Pathogens. Aptimmune Offering New Vaccination Technology. ISU and Aptimmune Improve PRRSV Isolation.